Inactive

FDA has a need to leverage the FDA low – or No-Cost Tech-Enabled Traceability Challenge to create a thorough and unbiased assessment of the traceability solutions received during the challenge. They n... FDA has a need to leverage the FDA low – or No-Cost Tech-Enabled Traceability Challenge to create a thorough and unbiased assessment of the traceability solutions received during the challenge. They need to also consider the evolution of traceability and related technology over the past ten years, using available information, whether publicly available or available through FDA. Lastly, they want to identify potential trends and insights into the future of the tech-enabled traceability landscape.